Abiopharma

Hologic Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX

EVNIN LUKE 🔴 sold 71.1K shares of Werewolf Therapeutics, Inc. (HOWL) at $0.65 Transaction Date: Jan 05, 2026 | Filing ID: 000002

Astria Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Astria Therapeutics, Inc. - ATXS

📋 Doherty James J. (Officer) plans to sell 2K shares of Acumen Pharmaceuticals, Inc. (at $1.99 each, total $3K) Filed: Jan 07, 2026 | ID: 000020

Kalofonos Isabel 🟡 adjusted position in 2.5K shares (1 derivative) of Crinetics Pharmaceuticals, Inc. (CRNX) at $55.00 Transaction Date: Jan 05, 2026 | Filing ID: 001230

📋 Roger Adsett (Officer) plans to sell 802 shares of INSMED INC (at $175.07 each, total $140K) Filed: Jan 07, 2026 | ID: 001229

(70% Positive) LENZ THERAPEUTICS, INC. (GRPH) Reports Q1 2026 Financial Results

New Form S-1 - CRESCENT BIOPHARMA, INC. Filed: 2026-01-07 AccNo: 0001628280-26-001227 Size: 35 MB

📋 Meisner Derek M (Officer) plans to sell 12K shares of Acumen Pharmaceuticals, Inc. (at $1.99 each, total $23K) Filed: Jan 07, 2026 | ID: 000019

New Form DEFA14A - Ventyx Biosciences, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-006527 Size: 649 KB

Director Gopaul Kevin Roy 🟢 acquired 100.0K shares of Streamex Corp. (STEX) Transaction Date: Jan 05, 2026 | Filing ID: 000838

📋 Michael Smith (Officer) plans to sell 709 shares of INSMED INC (at $175.07 each, total $124K) Filed: Jan 07, 2026 | ID: 001222

Director Gibson Christopher 🟡 adjusted position in 60.0K shares (10 derivative) of RECURSION PHARMACEUTICALS, INC. (RXRX) at $11.40 Transaction Date: Jan 05, 2026 | Filing ID: 000003

New SEC Form for ResMed Inc.

📋 Peter C Farrell (Director) plans to sell 2K shares of ResMed INC (at $248.79 each, total $498K) Filed: Jan 07, 2026 | ID: 001217